Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1494 Articles

Chris Lange | May 19, 2018 at 8:25 AM EDT

9 Companies Bracing for Big ASCO Reactions

This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.

Paul Ausick | May 18, 2018 at 9:45 AM EDT

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

The U.S. Food and Drug Administration on Thursday published a list of brand-name drug companies that the agency has received…

Paul Ausick | May 14, 2018 at 4:01 PM EDT

UnitedHealth, Walmart Buoy the Dow Monday

UnitedHealth, Walmart, Pfizer, and DowDuPont did their best to pin a small gain on the Dow Monday.

Chris Lange | May 10, 2018 at 10:20 AM EDT

Short Sellers Run for Cover From Major Pharma

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | May 1, 2018 at 4:01 PM EDT

Pfizer, Merck Sink the Dow Tuesday

Pfizer, Merck, McDonald's, and Coca-Cola were the big losers Tuesday among the 30 Dow stocks.

Chris Lange | May 1, 2018 at 9:55 AM EDT

How Much Pfizer Earnings Depend on a Few Brands

Pfizer reported mixed first-quarter financial results and full-year guidance before the markets opened on Tuesday.

Chris Lange | Apr 30, 2018 at 1:25 PM EDT

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Both Pfizer and Merck are scheduled to release their most recent quarterly results before the markets open on Tuesday. These…

Trey Thoelcke | Apr 29, 2018 at 10:15 AM EDT

Apple, McDonald’s, Pfizer and Other Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of Apple, McDonald's, Pfizer and other Dow companies scheduled to report their…

Chris Lange | Apr 25, 2018 at 8:35 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Apr 17, 2018 at 11:35 AM EDT

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S.…

Chris Lange | Apr 11, 2018 at 1:25 PM EDT

Pfizer’s Kidney Drug Not Up to Par

Pfizer shares were relatively muted after the pharma giant provided an update for its late-stage kidney trial.

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Apr 11, 2018 at 6:15 AM EDT

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the March 15 and March 29…

Chris Lange | Apr 2, 2018 at 1:20 PM EDT

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Pfizer shares took a small step back on Monday despite announcing positive results from a late-stage trial. The pullback seems…

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 35 36 37 38 39 … 100

Pfizer : PFE

All Pfizer Articles

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

UnitedHealth, Walmart Buoy the Dow Monday

Short Sellers Run for Cover From Major Pharma

Pfizer, Merck Sink the Dow Tuesday

How Much Pfizer Earnings Depend on a Few Brands

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Apple, McDonald’s, Pfizer and Other Dow Earnings Coming This Week

Short Sellers Grow More Selective on Major Pharma Stocks

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Pfizer’s Kidney Drug Not Up to Par

The Major Pharma Stocks That Are Making Short Sellers Sick

The 6 Most Shorted NYSE Stocks

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Which Major Pharma Stocks Short Sellers Are Keen On

Ripple and SBI Launch RLUSD in Japan After JFSA Approval

Here’s How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

Here's How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the "Strongest Move" for Social Security Benefits

Ripple and SBI Launch RLUSD in Japan After JFSA Approval

Here’s How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

Pfizer : PFE

All Pfizer Articles

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

UnitedHealth, Walmart Buoy the Dow Monday

Short Sellers Run for Cover From Major Pharma

Pfizer, Merck Sink the Dow Tuesday

How Much Pfizer Earnings Depend on a Few Brands

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Apple, McDonald’s, Pfizer and Other Dow Earnings Coming This Week

Short Sellers Grow More Selective on Major Pharma Stocks

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Pfizer’s Kidney Drug Not Up to Par

The Major Pharma Stocks That Are Making Short Sellers Sick

The 6 Most Shorted NYSE Stocks

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Which Major Pharma Stocks Short Sellers Are Keen On

Ripple and SBI Launch RLUSD in Japan After JFSA Approval

Here’s How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

Featured Reads

Here's How You Can Retire to Key West, Florida, at 62 on $1.6 Million and Never Feel Cold Again

91% of Retirees Fail to Make the "Strongest Move" for Social Security Benefits